Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and Food Effect of DS-1971a
NCT02266940Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Nov 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of DS-1971 in neuropathic pain (3 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Pharmacokinetics profile of DS-1971a at 3 days. Started Nov 2014; status: completed.
02
Drugs
DS-1971
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT02266940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02266940.